Regulatory considerations for developing drugs for rare diseases: orphan designations and early phase clinical trials. [electronic resource]
Producer: 20110930Description: 367-75 p. digitalISSN:- 1944-7930
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.